Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Vitale

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|December 22, 2025
Safety Of Hyperbaric Oxygen Therapy In Patients Aged 75 And Older: A Multicenter Retrospective StudyAndrea Neville Cracchiolo, Daniela Maria Palma, Erik Flavio Giuseppe Saporito, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2024
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysisSimeone D'Ambrosio, Fabio Salomone, Filippo Vitale, et al.
Translational Oncology|June 24, 2025
Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanomaLuigi Liguori, Angelo Luciano, Valentina Pagliara, et al.
Critical Reviews in Oncology/Hematology|September 20, 2025
Quality of life results and survival outcomes in trials of immunotherapy in advanced cancers: A systematic review and meta-research studyAnnarita Avanzo, Fabio Salomone, Massimo Di Maio, et al.
Journal of the National Cancer Institute|August 26, 2025
Censoring in trials testing immunotherapy in advanced cancers. A systematic review and a meta-research studyFilippo Vitale, Fabio Salomone, Massimo Di Maio, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Performance of Control Arms in Trials Leading to FDA Cancer Drug ApprovalsAngela Viggiano, Fabio Salomone, Fabiana Napolitano, et al.
Critical Reviews in Oncology/Hematology|December 18, 2025
Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysisFabio Salomone, Massimo Di Maio, Angela Viggiano, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|December 22, 2025
Safety Of Hyperbaric Oxygen Therapy In Patients Aged 75 And Older: A Multicenter Retrospective StudyAndrea Neville Cracchiolo, Daniela Maria Palma, Erik Flavio Giuseppe Saporito, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2024
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysisSimeone D'Ambrosio, Fabio Salomone, Filippo Vitale, et al.
Translational Oncology|June 24, 2025
Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanomaLuigi Liguori, Angelo Luciano, Valentina Pagliara, et al.
Critical Reviews in Oncology/Hematology|September 20, 2025
Quality of life results and survival outcomes in trials of immunotherapy in advanced cancers: A systematic review and meta-research studyAnnarita Avanzo, Fabio Salomone, Massimo Di Maio, et al.
Journal of the National Cancer Institute|August 26, 2025
Censoring in trials testing immunotherapy in advanced cancers. A systematic review and a meta-research studyFilippo Vitale, Fabio Salomone, Massimo Di Maio, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Performance of Control Arms in Trials Leading to FDA Cancer Drug ApprovalsAngela Viggiano, Fabio Salomone, Fabiana Napolitano, et al.
Critical Reviews in Oncology/Hematology|December 18, 2025
Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysisFabio Salomone, Massimo Di Maio, Angela Viggiano, et al.
Pageof 3